1. Myt1 kinase inhibitors - Insight into structural features, offering potential frameworks.
- Author
-
Tomović Pavlović, Katarina, Kocić, Gordana, and Šmelcerović, Andrija
- Subjects
- *
KINASE inhibitors , *CELL cycle , *DNA repair , *ENZYME inhibitors , *QUINOXALINES , *DNA damage - Abstract
The cell cycle includes two checkpoint arrests allowing to repair of damaged DNA. Many cancer cell lines exhibit weak G1 checkpoint mechanisms relying significantly more on the G2 checkpoint than do healthy cells. Inhibition of Myt1 kinase (PKMYT1), a forgotten member of the Wee family, cyclin-dependent kinase 1 (Cdk1) inhibitory kinase, target for G2 checkpoint abrogation, whose inhibition forces cells into premature unchecked mitosis resulting in cell death, is a promising concept for anticancer therapy. There are not many inhibitors of this emerging, potentially clinically important kinase. Herein, the valuable insight into structural features and binding mechanisms of diaminopyrimidines, aminoquinolines, quinazolines, pyrido[2,3- d ]pyrimidines, pyrazolo[3,4- d ]pyrimidines, and pyrrolo[2,3- b ]quinoxalines, as well as finally made a general scheme of fragmented structures of Myt1 inhibitors with the enzyme, offer potential frameworks useful for future directions, for further chemical optimizations, in the discovery and the design of novel effective structures, potential therapeutics. [Display omitted] • Inhibition of Myt1 kinase is promising concept for anticancer therapy. • Inhibitors of Myt1, regulator of G2/M transition, were reviewed and classified. • The most common scaffolds are diaminopyrimidine, aminoquinoline and 7-azaindole. • Fragmented schemes with common interaction patterns of inhibitors were consolidated. • Analyzed structural features offer potential frameworks for further optimizations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF